Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 3
1951 3
1952 2
1953 2
1955 1
1957 4
1958 1
1959 2
1960 1
1961 4
1963 1
1964 3
1965 3
1966 2
1968 2
1969 6
1970 4
1971 2
1972 5
1973 5
1974 6
1975 7
1976 9
1977 4
1978 8
1979 18
1980 12
1981 16
1982 16
1983 15
1984 16
1985 13
1986 26
1987 23
1988 21
1989 34
1990 20
1991 16
1992 25
1993 28
1994 32
1995 34
1996 31
1997 21
1998 37
1999 35
2000 28
2001 36
2002 31
2003 48
2004 38
2005 49
2006 38
2007 52
2008 48
2009 45
2010 63
2011 64
2012 85
2013 90
2014 101
2015 87
2016 110
2017 108
2018 97
2019 124
2020 112
2021 107
2022 100
2023 23
Text availability
Article attribute
Article type
Publication date

Search Results

2,045 results
Results by year
Filters applied: . Clear all
Page 1
Effects of Synbiotic Supplementation on Chronic Inflammation and the Gut Microbiota in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study.
Kanazawa A, Aida M, Yoshida Y, Kaga H, Katahira T, Suzuki L, Tamaki S, Sato J, Goto H, Azuma K, Shimizu T, Takahashi T, Yamashiro Y, Watada H. Kanazawa A, et al. Among authors: sato j. Nutrients. 2021 Feb 8;13(2):558. doi: 10.3390/nu13020558. Nutrients. 2021. PMID: 33567701 Free PMC article. Clinical Trial.
First-in-Human Phase 1 Study of MORAb-202, an Antibody-Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α-Positive Advanced Solid Tumors.
Shimizu T, Fujiwara Y, Yonemori K, Koyama T, Sato J, Tamura K, Shimomura A, Ikezawa H, Nomoto M, Furuuchi K, Nakajima R, Miura T, Yamamoto N. Shimizu T, et al. Among authors: sato j. Clin Cancer Res. 2021 Jul 15;27(14):3905-3915. doi: 10.1158/1078-0432.CCR-20-4740. Epub 2021 Apr 29. Clin Cancer Res. 2021. PMID: 33926914 Clinical Trial.
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial.
Hamada H, Suzuki H, Onouchi Y, Ebata R, Terai M, Fuse S, Okajima Y, Kurotobi S, Hirai K, Soga T, Ishiguchi Y, Okuma Y, Takada N, Yanai M, Sato J, Nakayashiro M, Ayusawa M, Yamamoto E, Nomura Y, Hashimura Y, Ouchi K, Masuda H, Takatsuki S, Hirono K, Ariga T, Higaki T, Otsuki A, Terauchi M, Aoyagi R, Sato T, Fujii Y, Fujiwara T, Hanaoka H, Hata A; KAICA trial Investigators. Hamada H, et al. Among authors: sato j. Lancet. 2019 Mar 16;393(10176):1128-1137. doi: 10.1016/S0140-6736(18)32003-8. Epub 2019 Mar 7. Lancet. 2019. PMID: 30853151 Clinical Trial.
Autoimmune gastritis induces aberrant DNA methylation reflecting its carcinogenic potential.
Takeuchi C, Sato J, Yamashita S, Sasaki A, Akahane T, Aoki R, Yamamichi M, Liu YY, Ito M, Furuta T, Nakajima S, Sakaguchi Y, Takahashi Y, Tsuji Y, Niimi K, Tomida S, Fujishiro M, Yamamichi N, Ushijima T. Takeuchi C, et al. Among authors: sato j. J Gastroenterol. 2022 Mar;57(3):144-155. doi: 10.1007/s00535-021-01848-2. Epub 2022 Jan 15. J Gastroenterol. 2022. PMID: 35034200
V2 vasopressin receptor mutations.
Makita N, Manaka K, Sato J, Iiri T. Makita N, et al. Among authors: sato j. Vitam Horm. 2020;113:79-99. doi: 10.1016/bs.vh.2019.08.012. Epub 2019 Sep 13. Vitam Horm. 2020. PMID: 32138955 Review.
Dexamethasone for cancer-related dyspnoea.
Nishimura R, Ishiki H, Sato J, Satomi E. Nishimura R, et al. Among authors: sato j. Lancet Oncol. 2022 Dec;23(12):e525. doi: 10.1016/S1470-2045(22)00657-X. Lancet Oncol. 2022. PMID: 36455574 No abstract available.
2,045 results